What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Disease
His primary areas of study are Intensive care medicine, Internal medicine, Acute kidney injury, Kidney disease and Nephrology.
His Intensive care medicine study incorporates themes from Dialysis and Hemodialysis.
His research integrates issues of Gastroenterology, Surgery and Cardiology in his study of Internal medicine.
His Acute kidney injury research integrates issues from Epidemiology, MEDLINE, Disease, Creatinine and Prospective cohort study.
His study in MEDLINE is interdisciplinary in nature, drawing from both Psychological intervention, Guideline, Renal angina and Consensus conference.
His Kidney disease research incorporates themes from Biomarker and Disease management.
His most cited work include:
- Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. (4950 citations)
- Acute Kidney Injury Network: Report of an Initiative to Improve Outcomes in Acute Kidney Injury (4929 citations)
- Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury (2704 citations)
What are the main themes of his work throughout his whole career to date?
Intensive care medicine, Acute kidney injury, Internal medicine, Renal replacement therapy and Dialysis are his primary areas of study.
Ravindra L. Mehta combines subjects such as Disease, MEDLINE and Kidney disease with his study of Intensive care medicine.
The study incorporates disciplines such as Developed country, Psychological intervention, Incidence, Renal function and Creatinine in addition to Acute kidney injury.
His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Surgery and Cardiology.
Ravindra L. Mehta interconnects Peritoneal dialysis and Hemofiltration in the investigation of issues within Renal replacement therapy.
His Dialysis research includes themes of Randomized controlled trial, Clinical trial and Hemodialysis.
He most often published in these fields:
- Intensive care medicine (64.62%)
- Acute kidney injury (56.55%)
- Internal medicine (31.20%)
What were the highlights of his more recent work (between 2017-2021)?
- Acute kidney injury (56.55%)
- Intensive care medicine (64.62%)
- Internal medicine (31.20%)
In recent papers he was focusing on the following fields of study:
Ravindra L. Mehta mainly investigates Acute kidney injury, Intensive care medicine, Internal medicine, MEDLINE and Kidney disease.
His Acute kidney injury study combines topics from a wide range of disciplines, such as Dialysis, Incidence, Emergency medicine and Renal function.
His work on Renal replacement therapy as part of general Intensive care medicine research is frequently linked to Best practice, bridging the gap between disciplines.
The Internal medicine study which covers Gastroenterology that intersects with Placebo.
His studies in MEDLINE integrate themes in fields like Kidney injury, Intensive care, Bronchoscopist and Medical emergency.
His Kidney disease research incorporates elements of Anesthesia, Kidney, Myocardial infarction and Comorbidity.
Between 2017 and 2021, his most popular works were:
- JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial. (70 citations)
- COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. (61 citations)
- Quality Improvement Goals for Acute Kidney Injury. (54 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Disease
His main research concerns Acute kidney injury, Internal medicine, MEDLINE, Disease and Intensive care medicine.
Ravindra L. Mehta has researched Acute kidney injury in several fields, including Heart failure, Emergency medicine, Biomarker, Dialysis and Intensive care unit.
His study in the field of Renal function, Kidney disease and Retrospective cohort study also crosses realms of Blocking.
His biological study spans a wide range of topics, including Tolerability, Randomized controlled trial and Myocardial infarction.
His MEDLINE research is multidisciplinary, incorporating elements of Incidence, Intensive care, Bronchoscopist and Medical emergency.
His work on Renal replacement therapy as part of general Intensive care medicine study is frequently linked to Best practice, bridging the gap between disciplines.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
